Home > Insider Trading > Filing (0001385508-20-000015)

Filing Details

Accession Number:: 0001385508-20-000015
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-09 16:12:15
Reporting Period:: 2020-01-07

Accepted Time:: 2020-01-09 16:12:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385508	Opiant Pharmaceuticals Inc.	OPNT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1358116	Phil Skolnick	C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd., Suite 280 Santa Monica CA 90401	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-01-07	2,900	$13.60	5,885	No	4	S	Direct
Common Stock	Acquisiton	2020-01-07	4,150	$0.00	10,035	No	4	A	Direct
Common Stock	Disposition	2020-01-08	2,842	$13.46	7,193	No	4	S	Direct
Common Stock	Disposition	2020-01-07	3,043	$13.36	4,150	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Acquisiton	2020-01-07	8,250	$0.00	8,250	$13.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,250		2030-01-07	No	4	A	Direct

Footnotes

The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $13.60 to $13.63. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4,150 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of January 7, 2021, January 7, 2022, January 7, 2023 and January 7, 2024, subject to the Reporting Person continuing as a service provider through each such date.
This transaction was executed in multiple trades at prices ranging from $13.26 to $13.59. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
On January 7, 2020, the reporting person was granted an option to purchase 8,250 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth year anniversary of the Grant Date.